NCT07380412 A Study to Evaluate the Effects of a Supplement on the Side Effects Associated With Stimulant Medications
| NCT ID | NCT07380412 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Outliers, Inc. |
| Condition | ADHD |
| Study Type | INTERVENTIONAL |
| Enrollment | 90 participants |
| Start Date | 2025-08-12 |
| Primary Completion | 2026-03 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 90 participants in total. It began in 2025-08-12 with a primary completion date of 2026-03.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This is a hybrid, two-arm, triple-blind, placebo-controlled, randomized clinical trial evaluating the efficacy of the Stasis supplement on reducing oxidative stress, cortisol levels, and side effects associated with stimulant medications used for ADHD over a three-month period in adults.
Eligibility Criteria
Inclusion Criteria: * Aged 18-55 years * Currently prescribed stimulant medication for ADHD * Experiencing: sleep difficulty, irritability, anxiety, brain fog * Stable medication dose ≥3 months * Healthy with no uncontrolled chronic conditions * Stable on supplements ≥3 months if applicable * US resident * Willing to maintain current habits Exclusion Criteria: * Chronic conditions (e.g. cancer, mental illness) * Use of psychiatric medications besides stimulants * Pregnancy, breastfeeding, thyroid, liver, kidney conditions * Recent smokers or heavy alcohol use * Night shift workers * Participation in other clinical trials * Allergies to product ingredients
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07380412 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 55 Years, studying ADHD. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07380412 currently recruiting?
Yes, NCT07380412 is actively recruiting participants. Contact the research team at hello@citruslabs.com for enrollment information.
Where is the NCT07380412 trial being conducted?
This trial is being conducted at Las Vegas, United States.
Who is sponsoring the NCT07380412 clinical trial?
NCT07380412 is sponsored by Outliers, Inc.. The trial plans to enroll 90 participants.